Douglas E. Williams

CIK: 0001184847

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)7 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

CAMP

Camp4 Therapeutics Corp

Director

CLYM

Climb Bio, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

CAMP
Camp4 Therapeutics Corp
Jun 10, 2026
Award(A)
Stock Option (Right to Buy)
Direct
28K shares-
CLYM
Climb Bio, Inc.
Jun 5, 2026
Award(A)
Stock Option (Right to Buy)
Direct
40K shares-
CLYM
Climb Bio, Inc.
Jun 4, 2025
Award(A)
Stock Option (Right to Buy)
Direct
40K shares-
CLYM
Climb Bio, Inc.
Mar 31, 2025
Award(A)
Stock Option (Right to Buy)
Direct
78.9K shares-
CAMP
Camp4 Therapeutics Corp
Mar 17, 2025
Award(A)
Stock Option (Right to Buy)
Direct
17.8K shares-
CLYM
Climb Bio, Inc.
Nov 11, 2024
Award(A)
Stock Option (Right to Buy)
Direct
20K shares-
CLYM
Climb Bio, Inc.
Nov 11, 2024
Award(A)
Stock Option (Right to Buy)
Direct
6.3K shares-

		Type	Shares	Price		Ownership
Jun 10, 2026	CAMP Camp4 Therapeutics Corp	Award(A) Stock Option (Right to Buy)	28,000	-	-	Direct
Jun 5, 2026	CLYM Climb Bio, Inc.	Award(A) Stock Option (Right to Buy)	40,000	-	-	Direct
Jun 4, 2025	CLYM Climb Bio, Inc.	Award(A) Stock Option (Right to Buy)	40,000	-	-	Direct
Mar 31, 2025	CLYM Climb Bio, Inc.	Award(A) Stock Option (Right to Buy)	78,873	-	-	Direct
Mar 17, 2025	CAMP Camp4 Therapeutics Corp	Award(A) Stock Option (Right to Buy)	17,787	-	-	Direct
Nov 11, 2024	CLYM Climb Bio, Inc.	Award(A) Stock Option (Right to Buy)	20,000	-	-	Direct
Nov 11, 2024	CLYM Climb Bio, Inc.	Award(A) Stock Option (Right to Buy)	6,291	-	-	Direct

1-7 of 7 transactions

About WILLIAMS DOUGLAS E

WILLIAMS DOUGLAS E (SEC CIK 0001184847) files insider reports with the SEC as Director of Camp4 Therapeutics Corp (CAMP) and Director of Climb Bio, Inc. (CLYM).

Signal8 holds 9 ownership filings by WILLIAMS DOUGLAS E (3 Form 3, 6 Form 4), filed between Nov 12, 2024 and Jun 12, 2026. Those filings report 7 transactions, from Nov 11, 2024 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on WILLIAMS DOUGLAS E's filings is in WELLESLEY HILLS, MA.

Recent filings by WILLIAMS DOUGLAS E

Jun 10, 2026: Grant or award of CAMP derivative securities (Form 4, code A).
Jun 5, 2026: Grant or award of CLYM derivative securities (Form 4, code A).
Jun 4, 2025: Grant or award of CLYM derivative securities (Form 4, code A).
Mar 31, 2025: Grant or award of CLYM derivative securities (Form 4, code A).
Mar 17, 2025: Grant or award of CAMP derivative securities (Form 4, code A).

Other insiders filing for Camp4 Therapeutics Corp (CAMP)

Gold Kelly, Chief Financial Officer
Schwab Andrew J., Director
Tardiff Daniel, Chief Scientific Officer
5AM Partners VI, LLC, 10% Owner
Young Richard A, Director
Maricich Yuri, Chief Medical Officer

How to read Form 4 transaction codes